1,123
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Impact of a killed PRRSV vaccine on sow longevity in a PRRSV infected swine herd

Pages 297-304 | Received 16 Jul 2011, Accepted 11 Apr 2012, Published online: 29 May 2012

Figures & data

Table 1. Results of routine mycotoxicological analysis in feed raw materials.

Table 2. Percentage of infected non-vaccinated animals (PRRSV-specific antibody titres >1:40) per semester prior and after the start of vaccination.

Figure 1.  Percentage of PRRSV – infected non-vaccinated animals (PRRSV-specific antibody titres >1:40) per semester prior and after the start of vaccinations.

Figure 1.  Percentage of PRRSV – infected non-vaccinated animals (PRRSV-specific antibody titres >1:40) per semester prior and after the start of vaccinations.

Figure 2.  Distribution of serological results based on PRRSV-specific antibody titres per semester in gilts prior and after the start of vaccinations (–1, +1, +2, +3, +4).

Figure 2.  Distribution of serological results based on PRRSV-specific antibody titres per semester in gilts prior and after the start of vaccinations (–1, +1, +2, +3, +4).

Table 3. Culling rate of female breeding stock (sows/gilts) per semester and totally prior and after the start of vaccination.

Table 4. Causes of culling in female breeding stock (sows/gilts) per semester and totally prior and after the start of vaccination.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.